Sun unit resolves antitrust lawsuit for $485m

24-03-2022

Muireann Bolger

Sun unit resolves antitrust lawsuit for $485m

Nils Versemann / Shutterstock.com

Sun Pharmaceuticals has agreed to pay $485 million to settle an antitrust lawsuit relating to a generic drug application filed by its subsidiary, Ranbaxy, ending years of litigation.


Sun Pharmaceuticals, Ranbaxy, antitrust, litigation

LSIPR